Transcatheter Aortic Valve Replacement News and Research

RSS

Octogenarians have better survival rates following heart valve surgery

Octogenarians need not shy away from heart valve surgery because of their age; however, those sent home following surgery do better than those discharged to care facilities, according to an observational study published in the September 2012 issue of The Annals of Thoracic Surgery.

30 Aug 2012

Surgeons perform two TAVR procedures at Toledo Hospital

Minimally invasive surgery is one of the biggest trends in health care as a safer alternative to major surgery. One of the newest procedures, approved this year by the Food and Drug Administration, is Transcatheter Aortic Valve Replacement (TAVR).

16 Aug 2012

UCLA performs first transcatheter aortic valve replacement using new device

UCLA has performed its first transcatheter aortic valve replacement (TAVR), using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who was not a candidate for open-heart surgery. The procedure took place August 9th.

16 Aug 2012

Baptist Cardiac & Vascular Institute offers new TAVR procedure for patients with aortic stenosis

People who are high-risk for heart valve surgery could have their damaged aortic valve replaced without traditional surgery with a new FDA-approved procedure performed at Baptist Cardiac & Vascular Institute at Baptist Hospital of Miami.

20 Jul 2012

JSUMC completes first procedure with TAVR

Jersey Shore University Medical Center proudly announces the completion of its first procedure with the Transcatheter Aortic Valve Replacement (TAVR), the latest minimally-invasive, life-saving innovation for non-operative patients with critical aortic stenosis.

1 Jun 2012

Neovasc first quarter revenues increase 46% to $1,712,991

Neovasc Inc., today announced financial results for the three months ended March 31, 2012.

29 May 2012

Positive results from Boston Scientific's Lotus Aortic Valve System trial

Boston Scientific Corporation announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus Aortic Valve System in patients with severe aortic valve disease.

16 May 2012

Less invasive procedure for heart disease

Doctors at Regions Hospital have begun performing a less invasive procedure for heart disease. Transcatheter aortic valve replacement (TAVR) was approved last November by the U.S. Food and Drug Administration for elderly patients who are too frail or too old for open heart surgery. The device is not approved for patients who are eligible for open heart surgery.

11 May 2012

Toshiba introduces two new software enhancements to facilitate TAVR procedures

To better facilitate transcatheter aortic valve replacement (TAVR) procedures, Toshiba America Medical Systems, Inc. introduces two new software enhancements that complement its Infinix-i cardiovascular X-ray systems.

9 May 2012

Enrollment complete in REPRISE I clinical trial for Lotus Aortic Valve System

Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.

23 Apr 2012

Toshiba's Infinix-i cardiovascular X-ray system highlighted at ACC 2012

The design of Toshiba's Infinix-i cardiovascular X-ray system improves patient access in the cath lab during transradial and transcatheter aortic-valve replacement (TAVR) intervention, resulting in better patient care and outcomes.

26 Mar 2012

Four leading organizations release recommendations to ensure optimal care of TAVR patients

Four leading heart organizations representing cardiologists and cardiothoracic surgeons released initial recommendations today for creating and maintaining transcatheter aortic valve replacement (TAVR) programs.

2 Mar 2012

U-M Cardiovascular Center now offers Edwards aortic valve replacement

As the population ages, more Americans will be susceptible to aortic stenosis, but not all patients can tolerate surgery to treat it. Select U.S. hospitals are now performing minimally invasive procedures called transcatheter aortic valve replacement, or TAVR, to replace a patient's diseased aortic valve without heart bypass or open heart surgery.

From Medtronic 23 Feb 2012

UMDNJ-RWJMS, RWJUH among the first to offer TAVR procedure

Physicians at Robert Wood Johnson University Hospital (RWJ) and UMDNJ-Robert Wood Johnson Medical School (RWJMS) are among the first in the nation to offer a groundbreaking aortic valve replacement technique that provides new treatment options and hope for patients diagnosed with severe aortic valve disease who are suffering from end-stage heart disease.

14 Feb 2012

Leading medical groups collaborate to ensure consistent, responsible uptake of TAVR

With the U.S. Food and Drug Administration's recent approval of transcatheter aortic valve replacement (TAVR) for patients with aortic valvular stenosis, the American College of Cardiology Foundation (ACCF), along with the American Association for Thoracic Surgery (AATS), the Society for Cardiovascular Angiography and Interventions (SCAI) and the Society of Thoracic Surgeons (STS), today released an expert consensus document to provide important guidance on its use.

1 Feb 2012

Scottsdale Healthcare is first in Arizona to perform TAVR procedure

Scottsdale Healthcare Osborn Medical Center is the first hospital in Arizona to perform a new nonsurgical heart valve replacement procedure, the Transcatheter Aortic Valve Replacement (TAVR). TAVR valves are inserted via a catheter through the femoral artery, without requiring open heart surgery.

6 Jan 2012

UofL surgeons perform first transcatheter aortic-valve replacement at Jewish Hospital

Some individuals with severe aortic stenosis - also known as narrowing of the aortic valve in the heart - who are not well enough to undergo open heart surgery have a new treatment option thanks to a new procedure now available in Kentucky from University of Louisville physicians at Jewish Hospital.

4 Jan 2012

USPTO issues Notice of Allowance to Emboline's aortic devices for TAVR procedures

Emboline, Inc., an emerging medical device company, has received Notice of Allowance from the United States Patent and Trademark Office (USPTO) related to its aortic embolic protection devices for percutaneous heart valve repair and replacement.

1 Dec 2011

Study examines potential cost effectiveness of TAVR versus SAVR

The cost effectiveness of transcatheter aortic valve implantation (TAVR) compared to surgical aortic valve replacement (SAVR) depends on whether TAVR is performed via the femoral artery or transapically, through a small incision in the chest, according to a new study.

11 Nov 2011

Positive results from InSeal's intravascular large bore puncture closure device trial

InSeal Medical Ltd., developer of percutaneous vascular closure devices for large bore punctures, today announced the successful treatment of three patients with its investigational intravascular large bore puncture closure device.

10 Nov 2011